BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38750462)

  • 1. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
    Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
    J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
    Lai Q; Wan Y; Zhang Y; Huang Y; Tang Q; Chen M; Li Q; Ma K; Xiao P; Luo C; Zhuang X
    Mol Carcinog; 2024 Jul; 63(7):1260-1274. PubMed ID: 38607240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
    Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
    Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
    Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1.
    Yang M; Wei Y; He X; Xia C
    Biol Direct; 2024 Jun; 19(1):46. PubMed ID: 38880876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSPE1 enhances aerobic glycolysis to promote progression of lung adenocarcinoma.
    Xie T; Li M
    Mutat Res; 2024 Jun; 829():111867. PubMed ID: 38878504
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Feng B; Wang X; Qiu D; Sun H; Deng J; Tan Y; Ji K; Xu S; Zhang S; Tang C
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5.
    Shi Y; Pan Z; Feng Y; Zhou Q; Wang Q; Wang H; Dong G; Xia W; Jiang F
    Carcinogenesis; 2024 Jun; 45(6):409-423. PubMed ID: 38366384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.
    Zhao R; Guo Y; Zhang L; Huang Z; Li X; Lan B; Zhong D; Chen H; Xuan C
    Cell Death Dis; 2024 May; 15(5):378. PubMed ID: 38816356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
    Liu G; Liu X; Zeng W; Zhou W
    Pharmacology; 2024 Apr; ():1-14. PubMed ID: 38643755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncARSR promotes glioma tumor growth by mediating glycolysis through the STAT3/HK2 axis.
    Tian Z; Dai Q; Liu B; Lin H; Ou H
    Cytokine; 2024 May; 180():156663. PubMed ID: 38815522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma.
    Wang D; Cao Y; Meng M; Qiu J; Ni C; Guo X; Li Y; Liu S; Yu J; Guo M; Wang J; Du B; Qiu W; Xie C; Zhao B; Ma X; Cheng X; Xu L
    PLoS Biol; 2024 May; 22(5):e3002621. PubMed ID: 38805565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00908 attenuates LUAD tumorigenesis through DEAD-box helicase 54.
    Zhao J; Yang X; Gong W; Zhang L; Li C; Han X; Zhang Y; Chu X
    Am J Cancer Res; 2024; 14(5):2371-2389. PubMed ID: 38859824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.
    Yu SK; Yu T; Wang YM; Sun A; Liu J; Lu KH
    J Transl Med; 2024 May; 22(1):460. PubMed ID: 38750462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.
    Fattahi M; Rezaee D; Fakhari F; Najafi S; Aghaei-Zarch SM; Beyranvand P; Rashidi MA; Bagheri-Mohammadi S; Zamani-Rarani F; Bakhtiari M; Bakhtiari A; Falahi S; Kenarkoohi A; Majidpoor J; Nguyen PU
    Cell Death Discov; 2023 Nov; 9(1):423. PubMed ID: 38001121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas.
    Wu Z; Deng L; Tao J; Lu Y; Zeng X; Jia W; Chen H
    J Cancer; 2023; 14(17):3238-3247. PubMed ID: 37928427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.
    Huang C; Azizi P; Vazirzadeh M; Aghaei-Zarch SM; Aghaei-Zarch F; Ghanavi J; Farnia P
    J Transl Med; 2023 Sep; 21(1):621. PubMed ID: 37705098
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.